Tech Company Financing Transactions
Conceivable Life Sciences Funding Round
ARTIS Ventures, ACME Capital and Atlantic Health System participated in a $18 million Series A venture round for Conceivable Life Sciences. The financing round was announced on 1/15/2025.
Transaction Overview
Company Name
Announced On
1/15/2025
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support the ongoing commercial pilot program in Mexico City and preparations for U.S. launch timed for early 2026.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Conceivable Life Sciences, a NYC-based biotech company which specializes in fertility care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alan Murray
Browse more venture capital transactions:
Prev: 1/15/2025: ButterflyMX venture capital transaction
Next: 1/15/2025: Hinge Bio venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs